Biopharmaceutical Contract Manufacturing 2018 Global Industry Size,Analysis,Opportunities,Forecasts to 2023

WiseGuyReports.Com adds “Biopharmaceutical Contract Manufacturing 2018 Global Industry Size,Analysis,Opportunities,Forecasts to 2023” Research to its Database.

Description:

Biopharmaceutical Contract Manufacturing Market

Biopharmaceuticals are also known as biologics. Biopharmaceutical products are pharmaceutical drugs that are synthesized, processed, or extracted from biological sources. Biopharmaceuticals include vaccines, blood products, recombinant therapeutic proteins, allergens, gene therapies, tissues and living cells used in cell therapy. Many companies outsource the manufacturing of biopharmaceuticals due to lack of manufacturing capabilities or in order to reduce the cost of manufacture process.Contract manufacturing organizations offer a wide range of services such as cell line development, process optimization, fermentation biotechnology, analytical characterization, cGMP manufacturing, and validation in each stage of clinical development and commercialization.

Biopharmaceutical contract manufacturing market is mainly driven by increase in investment of the pharma and biotechnological companies to develop and commercialize the biotechnological products. In addition, high revenue generation of blockbuster biological drugs such as humira, rituxan, lantus, avastin, herceptin and remicade are gaining traction from many biologics manufacturers. Advancements in the biotechnology such as recombinant DNA technologies and targeted drug therapies are expected to bolster the biopharmaceutical contract manufacturing market over the forecast period. Furthermore, to meet demand for biological products, companies are outsourcing the biopharmaceutical manufacturing to various contract manufacturing companies. However, high cost associated with manufacture and stringent regulatory requirements are expected to hamper the growth of biopharmaceutical contract manufacturing market.

Get a Sample Report @ https://www.wiseguyreports.com/sample-request/2753910-global-biopharmaceutical-contract-manufacturing-market-2012-to-2023

For more information or any query mail at sales@wiseguyreports.com

Biopharmaceutical contract manufacturing market segmented based on manufacturing process, type of services, molecule type and end user

Based on manufacturing process, biopharmaceutical contract manufacturing market is segmented into
Mammalian Based
Microbial Based
Insect Based
Plant Based
Yeast Based
Others

Based on type of service, biopharmaceutical contract manufacturing market is segmented into
Formulation
Fill and Finish services
Cell Banking
Analytical Services
Process development
Others

Based on molecule type, biopharmaceutical contract manufacturing market is segmented into
Large Molecules
Small Molecules

Based on end-user, biopharmaceutical contract manufacturing market is segmented into
Biopharmaceutical Companies
Pharmaceutical Companies
Research Organizations
Others

Global biopharmaceutical contract manufacturing market is expected to grow at a significant rate during the forecast period. The market is highly competitive where the speed to market is imperative along with efficient process and low costs. Biopharmaceutical contract manufacturing services providers are increasing their service offerings such as formulation, production and analytical services apart from conventional services to provide complete support for biopharmaceutical companies. Cost considerations and quick services are expected continue to drive the outsourcing of biopharmaceutical contract manufacturing market. In May 2017, Lonza Group Ltd. acquired cell and gene contract manufacturer PharmaCell B.V., this acquisition broadens Lonza’s capabilities in Europe region. Companies expanding the manufacturing facilities to increase market share. For instance, In May 2017, Boehringer Ingelheim GmbH started a new manufacturing facility in China to increase their manufacturing capacity. Through this facility company’s manufacturing capacity will increase by one-third.

Geographically biopharmaceutical contract manufacturing market has been segmented into following regions viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America and Europe are expected to be leading in biopharmaceutical contract manufacturing owing to increased approvals of biosimilars and increase in biopharmaceutical research organization which are lack of manufacturing facilities. In Asia-Pacific region, emerging countries such as China and India expected to grow at a rapid rate owing to low cost of manufacturing. Development of biologics pipeline by domestic companies expected to drive the growth of biopharmaceutical contract manufacturing in China.

Some of the players in biopharmaceutical contract manufacturing market are Lonza Group Ltd. (Switzerland), Boehringer Ingelheim GmbH (Germany), Charles River Laboratories, Inc. (U.S), Novartis AG (Switzerland) WuXi AppTec Group (China), Rentschler Biotechnologie GmbH (Germany), Fujifilm Holdings Corporation (Japan), Celonic AG (Switzerland), BIOMEVA GmbH (Germany), and ProBioGen AG (Germany) to name a few.

In June 2016, Moderna Therapeutics and Charles River Laboratories International, Inc., an early-stage contract research organization (CRO), are collaborated to support Moderna’s nonclinical discovery and development efforts.

Ask Query @ https://www.wiseguyreports.com/enquiry/2753910-global-biopharmaceutical-contract-manufacturing-market-2012-to-2023

Table Of Contents – Major Key Points

1. Executive Summary

2. Global Biopharmaceutical Contract Manufacturing Market Introduction
2.1. Global Biopharmaceutical Contract Manufacturing Market – Taxonomy
2.2. Global Biopharmaceutical Contract Manufacturing Market –Definitions
2.2.1. Manufacturing Process
2.2.2. Type of Service
2.2.3. Molecule Type
2.2.4. End-Use Type

3. Global Biopharmaceutical Contract Manufacturing Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Biopharmaceutical Contract Manufacturing Market Dynamic Factors - Impact Analysis
3.6. Global Biopharmaceutical Contract Manufacturing Market – Regulations
3.6.1. U.S.
3.6.2. Europe
3.7. Global Biopharmaceutical Contract Manufacturing Market –Trends

4. Global Biopharmaceutical Contract Manufacturing Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023
4.1. Market Analysis, 2012 – 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis

5. Global Biopharmaceutical Contract Manufacturing Market, By Manufacturing Process, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.1. Mammalian Based
5.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Microbial Based
5.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Insect Based
5.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Plant Based
5.4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Yeast Based
5.5.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
5.6. Others
5.6.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.6.3. Market Opportunity Analysis

6. Global Biopharmaceutical Contract Manufacturing Market Forecast, By Type of Service, 2012 - 2016 and Forecast, 2017 – 2023
6.1. Formulation
6.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Fill and Finish services
6.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Cell Banking
6.3.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Analytical Services
6.4.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Process development
6.5.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
6.6. Others
6.6.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.6.3. Market Opportunity Analysis

7. Global Biopharmaceutical Contract Manufacturing Market Forecast, By Molecule Type, 2012 - 2016 and Forecast, 2017 – 2023
7.1. Large Molecules
7.1.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Small Molecules
7.2.1. Market Analysis, 2012 - 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis

Continue…….

Buy 1-User PDF @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=2753910

For more information or any query mail at sales@wiseguyreports.com

ABOUT US:
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.

Office No.528,Amanora Chambers,Magarpatta Road,Hadapsar,Pune-411028.

This release was published on openPR.